Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wolk

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Brain : a Journal of Neurology|January 15, 2021
The development and convergence of co-pathologies in Alzheimer's diseaseJohn L Robinson, Hayley Richardson, Sharon X Xie, et al.
Neurobiology of Aging|March 1, 2023
Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's diseaseBenjamin J Kim, Murray Grossman, Tomas S Aleman, et al.
Research Square|January 23, 2024
Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individualsChengjie Xiong, Suzanne Schindler, Jingqin Luo, et al.
Molecular Neurodegeneration|April 9, 2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degenerationAlba Cervantes González, David J Irwin, Daniel Alcolea, et al.
Neurology. Clinical Practice|April 12, 2021
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJiasi Vicky Zhang, David J Irwin, Kaj Blennow, et al.
Annals of Clinical and Translational Neurology|October 27, 2020
Tau pathology associates with in vivo cortical thinning in Lewy body disordersNicola Spotorno, David G Coughlin, Christopher A Olm, et al.
JAMA Neurology|December 4, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement DisordersBob Olsson, Erik Portelius, Nicholas C Cullen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2013
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease BiobankJon B Toledo, Vivianna M Van Deerlin, Edward B Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2025
Assessing the Global Impact of Brain Small Vessel Disease on Cognition: The Multi-Ethnic Study of AtherosclerosisSokratis Charisis, Tanweer Rashid, Christina Dintica, et al.
Brain : a Journal of Neurology|June 8, 2018
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associatedJohn L Robinson, Edward B Lee, Sharon X Xie, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Brain : a Journal of Neurology|January 15, 2021
The development and convergence of co-pathologies in Alzheimer's diseaseJohn L Robinson, Hayley Richardson, Sharon X Xie, et al.
Neurobiology of Aging|March 1, 2023
Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's diseaseBenjamin J Kim, Murray Grossman, Tomas S Aleman, et al.
Research Square|January 23, 2024
Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individualsChengjie Xiong, Suzanne Schindler, Jingqin Luo, et al.
Molecular Neurodegeneration|April 9, 2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degenerationAlba Cervantes González, David J Irwin, Daniel Alcolea, et al.
Neurology. Clinical Practice|April 12, 2021
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJiasi Vicky Zhang, David J Irwin, Kaj Blennow, et al.
Annals of Clinical and Translational Neurology|October 27, 2020
Tau pathology associates with in vivo cortical thinning in Lewy body disordersNicola Spotorno, David G Coughlin, Christopher A Olm, et al.
JAMA Neurology|December 4, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement DisordersBob Olsson, Erik Portelius, Nicholas C Cullen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2013
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease BiobankJon B Toledo, Vivianna M Van Deerlin, Edward B Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2025
Assessing the Global Impact of Brain Small Vessel Disease on Cognition: The Multi-Ethnic Study of AtherosclerosisSokratis Charisis, Tanweer Rashid, Christina Dintica, et al.
Brain : a Journal of Neurology|June 8, 2018
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associatedJohn L Robinson, Edward B Lee, Sharon X Xie, et al.
Pageof 4